"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
| Descriptor ID |
D000368
|
| MeSH Number(s) |
M01.060.116.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 126 | 126 |
| 1997 | 2 | 142 | 144 |
| 1998 | 2 | 133 | 135 |
| 1999 | 0 | 170 | 170 |
| 2000 | 1 | 199 | 200 |
| 2001 | 2 | 198 | 200 |
| 2002 | 3 | 243 | 246 |
| 2003 | 2 | 298 | 300 |
| 2004 | 1 | 327 | 328 |
| 2005 | 0 | 369 | 369 |
| 2006 | 0 | 354 | 354 |
| 2007 | 0 | 371 | 371 |
| 2008 | 2 | 421 | 423 |
| 2009 | 1 | 461 | 462 |
| 2010 | 0 | 512 | 512 |
| 2011 | 0 | 597 | 597 |
| 2012 | 0 | 600 | 600 |
| 2013 | 0 | 721 | 721 |
| 2014 | 1 | 713 | 714 |
| 2015 | 0 | 790 | 790 |
| 2016 | 0 | 823 | 823 |
| 2017 | 0 | 886 | 886 |
| 2018 | 0 | 928 | 928 |
| 2019 | 0 | 864 | 864 |
| 2020 | 0 | 834 | 834 |
| 2021 | 0 | 678 | 678 |
| 2022 | 0 | 333 | 333 |
| 2023 | 0 | 297 | 297 |
| 2024 | 0 | 911 | 911 |
| 2025 | 0 | 964 | 964 |
| 2026 | 0 | 202 | 202 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea. Blood. 2026 May 07; 147(19):2215-2225.
-
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases. Brain. 2026 May 05; 149(5):1635-1649.
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
-
THE "SCOLEX" SIGN: A Distinct Hyperreflective Foci on the Wall of Serous Pigment Epithelial Detachments in Central Serous Chorioretinopathy - Micron Report Number Seven. Retina. 2026 May 01; 46(5):871-880.
-
A smoking-related plasma protein score and smoking-related cancer risk and mortality in the Atherosclerosis Risk in Communities study. J Natl Cancer Inst. 2026 May 01; 118(5):917-925.
-
Treatment Adherence to Oral Direct-Acting Antiviral Agents in Hepatitis C Infection. Pharmacotherapy. 2026 May; 46(5):e70126.
-
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenstr?m macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial. Lancet Haematol. 2026 May; 13(5):e284-e296.
-
Appendiceal Adenocarcinoma Cytoreduction Outcomes and Perioperative Serum Tumor Marker Levels. JAMA Netw Open. 2026 May 01; 9(5):e2610569.
-
Using the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics. Clin Infect Dis. 2026 Apr 30; 82(4):e674-e681.
-
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026 04 30; 147(18):2041-2052.